"Klinische Forschung, kontrollierte experimentelle Therapie, Herr Prof. Dr. Tilman Todenhöfer und Frau Dr. Susan Feyerabend"

During the past decade, Studienpraxis Urologie conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 10 clinical trials were completed, i.e. on average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 7 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Studienpraxis Urologie" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Clovis Oncology, Inc." with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Studienpraxis Urologie" #1 collaborator was "Foundation Medicine" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator and "Janssen Pharmaceutica N.V., Belgium" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Studienpraxis Urologie" are "Prostate Cancer" (7 trials), "Prostatic Neoplasms" (5 trials), "Prostate Cancer Metastatic" (4 trials), "Metastatic Castration Resistant Prostate Cancer" (2 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Studienpraxis Urologie" in a lesser frequency.

Most popular intervention types in "Studienpraxis Urologie" are "Drug" (28 trials), "Biological" (9 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Prednisone" (6 trials), "Pembrolizumab" (4 trials), "Docetaxel" (3 trials) and "Rucaparib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Studienpraxis Urologie" are 24 trials for "Male" genders and 7 trials for "All" genders.

Currently, there are NaN active trials in "Studienpraxis Urologie". undefined are not yet recruiting, 9 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Studienpraxis Urologie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Studienpraxis Urologie, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".